Filing Details
- Accession Number:
- 0001209191-14-059774
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-25 16:23:01
- Reporting Period:
- 2014-09-23
- Filing Date:
- 2014-09-25
- Accepted Time:
- 2014-09-25 16:23:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1296998 | Guy Macdonald | 480 Arsenal St. Suite 110 Watertown MA 02472 | President And Chief Executive | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-23 | 9,641 | $2.03 | 59,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-23 | 359 | $2.03 | 60,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-23 | 10,000 | $18.47 | 50,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-09-23 | 9,641 | $0.00 | 9,641 | $2.03 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-09-23 | 359 | $0.00 | 359 | $2.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 79,361 | 2020-09-27 | No | 4 | M | Direct | |
| 12,534 | 2022-06-05 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2013.
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $18.00 to $18.78 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Fully vested.
- This option was granted on June 6, 2012 with respect to 12,893 shares of Common Stock, with 6.25% vesting at the end of each successive three month period until June 6, 2016.
Billionaire Hedge Funds
